Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Galectin Therapeutics Q1 EPS $(0.11) Down From $(0.06) YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.11) per share. This is a 83.33 percent decrease over losses of $(0.06) per share from the same period last year.

byBenzinga Newsdesk

May 17, 2021

1 minute read

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.11) per share. This is a 83.33 percent decrease over losses of $(0.06) per share from the same period last year.

Raymond James Downgrades Extra Space Storage to Market Perform

By Benzinga Newsdesk

Today, 8:17 AM

Raymond James analyst Jonathan Hughes downgrades Extra Space Storage (NYSE:EXR) from Outperform to Market Perform.

EXR

LPL Financial Holdings Q2 EPS $2.24 Beats $1.97 Estimate, Sales $2.04B Miss $2.12B Estimate

By Benzinga Newsdesk

Today, 8:17 AM

LPL Financial Holdings (NASDAQ:LPLA) reported quarterly earnings of $2.24 per share which beat the analyst consensus estimate of $1.97 by 13.71 percent. This is a 21.08 percent increase over earnings of $1.85 per share

LPLA

Anterix To Lease 900 MHz Spectrum To Evergy For Kansas, Missouri

By Anusuya Lahiri

Today, 8:17 AM

Anterix Inc (NASDAQ:ATEX) agreed to a long-term lease of its 900 MHz broadband spectrum throughout Evergy Inc’s (NYSE:EVRG) 28,130-square mile service territory in…

AEE